EAM Investors’s Guardant Health GH Stock Holding History

EAM Investors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2M	Buy	+81,304	New	+$8.84M	1.09%	4
2026 Q1	–	Sell	-71,074	Closed	-$7.26M	–	311
2025 Q4	$7.26M	Sell	71,074 -1,421	-2%	-$127K	0.81%	8
2025 Q3	$4.46M	Buy	+72,495	New	+$3.94M	0.51%	85
2025 Q2	–	Sell	-107,896	Closed	-$4.6M	–	284
2025 Q1	$4.6M	Buy	+107,896	New	+$4.66M	0.79%	19
2019 Q3	–	Sell	-14,996	Closed	-$1.29M	–	262
2019 Q2	$1.29M	Sell	14,996 -1,380	-8%	-$105K	0.32%	149
2019 Q1	$1.26M	Sell	16,376 -22,445	-58%	-$1.24M	0.31%	150
2018 Q4	$1.46M	Buy	+38,821	New	+$1.43M	0.4%	115

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

EAM Investors's GH Position: Q2 2026 in Review

EAM Investors opened a new position in Guardant Health (GH) in Q2 2026: 81,304 shares worth $12.2M. The stake represents 1.09% of the portfolio and ranks #4 among its holdings. This is a return to the name: EAM Investors previously reported a position in GH as recently as Q4 2025.

EAM Investors first reported a position in GH in Q4 2018 and has held it in 7 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

EAM Investors held 81,304 shares of Guardant Health worth $12.2M as of Q2 2026.
Guardant Health was a new EAM Investors position in Q2 2026.
Guardant Health made up 1.09% of EAM Investors's portfolio in Q2 2026, its #4 holding.
EAM Investors first reported a position in Guardant Health in Q4 2018 and has held it in 7 quarters since.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.